Perspectives of healthcare providers on implementation of long‐acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation‐effectiveness study (CUSTOMIZE)

INTRODUCTION: CUSTOMIZE evaluated the implementation of long‐acting (LA) cabotegravir + rilpivirine, a novel healthcare provider–administered injectable antiretroviral therapy regimen, in diverse US healthcare settings. Findings from staff‐study participants (SSPs) through 12 months of implementatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnogorski, Maggie, Garris, Cindy P., Dalessandro, Marybeth, D'Amico, Ronald, Nwafor, Toyin, Williams, Will, Merrill, Deanna, Wang, YuanYuan, Stassek, Larissa, Wohlfeiler, Michael B., Sinclair, Gary I., Mena, Leandro A., Thedinger, Blair, Flamm, Jason A., Benson, Paul, Spreen, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465974/
https://www.ncbi.nlm.nih.gov/pubmed/36094142
http://dx.doi.org/10.1002/jia2.26003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465974/
https://www.ncbi.nlm.nih.gov/pubmed/36094142
http://dx.doi.org/10.1002/jia2.26003

Ejemplares similares